Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2012
10/25/2012US20120270268 Anti-CD100 Neutralizing Antibodies and Methods of Using the Same
10/25/2012US20120270267 Alpha-Amylases
10/25/2012US20120270266 Nucleic ac1d and amino ac1d sequences encoding high-level expressor factor viii polypeptides and methods of use
10/25/2012US20120270265 Methods of obtaining a specific binding member that binds eotaxin
10/25/2012US20120270264 Dna construct, and process for production of recombinant cho cell using same
10/25/2012US20120270240 Detection Reagents for Tyrosine Kinase Activity and Methods of Use Thereof
10/25/2012US20120270234 Ddr2 protein with activated kinase activity and preparation method thereof
10/25/2012US20120270232 Characterization of granulocytic ehrlichia and methods of use
10/25/2012US20120270230 Mutant g-protein coupled receptors and methods for selecting them
10/25/2012US20120270222 Method for the Efficiency-Corrected Real-Time Quantification of Nucleic Acids
10/25/2012US20120270220 Detection of nucleic acid sequence differences using coupled ligase detection and polymerase chain reactions
10/25/2012US20120270219 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses
10/25/2012US20120269858 Polypeptides
10/25/2012US20120269855 Toll-like receptor 5 ligands and methods of use
10/25/2012US20120269854 Method of Enhancing KSHV LANA1 Immunogenicity
10/25/2012US20120269851 Expression cassettes endcoding hiv-1 south african subtype c modified proteins
10/25/2012US20120269850 Method of Inducing an Immune Response
10/25/2012US20120269849 Attenuated influenza viruses and vaccines
10/25/2012US20120269843 S. epidermidis antigens
10/25/2012US20120269842 Enterotoxigenic e. coli fusion protein vaccines
10/25/2012US20120269840 Expression of hiv polypeptides and production of virus-like particles
10/25/2012US20120269837 SUBSTANCE BINDING HUMAN IgG Fc RECEPTOR IIb (FcgammaRIIb)
10/25/2012US20120269835 Process for the production of immunogenic compositions
10/25/2012US20120269832 Mature Dendritic Cell Compositions and Methods of Culturing Same
10/25/2012US20120269829 Inhibitors of Phosphatase and Tensin Homolog (PTEN) Compositions, Uses and Methods
10/25/2012US20120269822 Anti-Botulinum Neurotoxin a Single Domain Antibody Antibodies
10/25/2012US20120269821 Hiv-1 antibodies
10/25/2012US20120269820 Anti-il 17a/il-17f cross-reactive antibodies and methods of use thereof
10/25/2012US20120269817 Monoclonal Antibodies Against Tissue Factor Pathway Inhibitor
10/25/2012US20120269814 Anti-c mpl antibodies
10/25/2012US20120269807 COMPOSITIONS AND METHODS FOR BLOOD-BRAIN BARRIER DELIVERY OF lgG-DECOY RECEPTOR FUSION PROTEINS
10/25/2012US20120269795 Humanized recombinant uricase and mutants thereof
10/25/2012US20120269788 Antidotes for factor xa inhibitors and methods of using the same
10/25/2012US20120269778 Methods of generating neural stem cells
10/25/2012US20120269773 Recombinant adenoviruses encoding the specific iodine transporter (nis)
10/25/2012US20120269765 Cytokine compositions and methods of use thereof
10/25/2012US20120269702 Structure and method for handling magnetic particles in biological assays
10/25/2012DE69429452C5 Herstellungsverfahren einer substanz Manufacturing process of a substance
10/25/2012DE102011118949B3 Combined method for differential diagnostic detection of bacteria of e.g. Mycobacterium tuberculosis complex and Chlamydophila pneumoniae, where the method is performed on the basis of a real-time PCR using labeled probes
10/24/2012EP2515121A1 Sample processing device, sample processing method, and reaction container used in these device and method
10/24/2012EP2514835A1 Method for analyzing cervical lymph node metastasis, and tumor marker for head and neck cancer
10/24/2012EP2514827A1 CNS gene delivery using peripheral administration of AAV10 vectors
10/24/2012EP2514826A2 Use of interfering RNA molecules to down regulate the expression of specific genes or family of genes
10/24/2012EP2514825A2 Disease resistant plants
10/24/2012EP2514824A2 Methods and compositions to treat and detect misfolded-SOD1 mediated diseases
10/24/2012EP2514823A2 Methods and compositions to treat and detect misfolded-SOD1 mediated diseases
10/24/2012EP2514822A1 Anti-thrombosis aptamers and method for stabilizing the structure thereof
10/24/2012EP2514821A1 Cystatin c, beta2 microglobulin, alpha1 microglobulin and genes for same, antibody, and kit and method for diagnosis of feline nephropathy
10/24/2012EP2514820A1 Method for designing probe in dna microarray, and dna microarray provided with probe designed thereby
10/24/2012EP2514818A2 Glucoamylase variants
10/24/2012EP2514816A2 Method of manufacturing reference material using plant cultured cell lines
10/24/2012EP2514768A1 Fusion polypeptide against eb virus-induced tumor and colicin ia mutant
10/24/2012EP2514765A1 Gpr177 as target and marker in tumors
10/24/2012EP2514764A2 Antibody molecules which bind IL-17A and IL-17F
10/24/2012EP2514763A1 Egf receptor epitope peptides and uses thereof
10/24/2012EP2514762A2 B7-DC variants
10/24/2012EP2514758A1 Methods and compositions for the specific inhibition of gene expression by double-stranded RNA
10/24/2012EP2514303A1 Hybrid seed potato breeding
10/24/2012EP2514302A1 Process for production of multi-petaled cyclamen
10/24/2012EP2513335A2 Method and materials for separating nucleic acid materials
10/24/2012EP2513334A1 Dicer substrate agents and methods for the specific inhibition of gene expression
10/24/2012EP2513323A2 Heterologous hosts
10/24/2012EP2513319A1 Plant genes associated with seed oil content and methods of their use
10/24/2012EP2513318A1 Use of cry1ab in combination with cry1be for management of resistant insects
10/24/2012EP2513317A1 Use of cry1da in combination with cry1be for management of resistant insects
10/24/2012EP2513316A1 Use of cry1da in combination with cry1ca for management of resistant insects
10/24/2012EP2513315A1 Combined use of cry1fa and cry1ab proteins for control of cry-resistant sugarcane borer and for insect resistance management in sugarcane
10/24/2012EP2513314A1 Combined use of cry1ca and cry1ab proteins for insect resistance management
10/24/2012EP2513313A1 Substances and methods for the treatment of lysosmal storage diseases
10/24/2012EP2513312A2 Synthetic polypeptide libraries and methods for generating naturally diversified polypeptide variants
10/24/2012EP2513311A1 Production of ifn-lambda by conventional dendritic cells and uses thereof
10/24/2012EP2513310A2 Treatment of membrane bound transcription factor peptidase, site 1 (mbtps1) related diseases by inhibition of natural antisense transcript to mbtps1
10/24/2012EP2513309A2 Organic compositions to treat hsf1-related diseases
10/24/2012EP2513308A1 Modulation of pilr to treat immune disorders
10/24/2012EP2513307A1 Micro-rna regulation in ischemia and ischemia-reperfusion injury
10/24/2012EP2513306A2 C. histolyticum recombinant collagenases and method for the manufacture thereof
10/24/2012EP2513305A1 Secretion system on the basis of a hydrophobin signal sequence from trichoderma reesei
10/24/2012EP2513304A2 Toxin-immunity system
10/24/2012EP2513301A1 Pichia pastoris deficient in endogenous secreted protease
10/24/2012EP2513290A2 Methods for producing polypeptides in protease-deficient mutants of trichoderma
10/24/2012EP2513138A1 Modified ubiquitin proteins having a specific binding activity for the extradomain b of fibronectin
10/24/2012EP2513136A1 Tmem22 peptides and vaccines including the same
10/24/2012EP2512514A1 Pharmaceutical composition for prevention and treatment of amyotrophic lateral sclerosis
10/24/2012EP2512512A1 Uniform field magnetization and targeting of therapeutic formulations
10/24/2012EP2512505A2 Modified clostridial toxins comprising an integrated protease cleavage site-binding domain
10/24/2012EP2512449A1 Methods and compositions for delivery of nucleic acids
10/24/2012EP2512227A1 Animal model expressing luciferase under control of the myelin basic protein promoter (mbp-luci) and use of the model for bioluminescence in vivo imaging
10/24/2012EP2512226A1 Maize event dp-004114-3 and methods for detection thereof
10/24/2012EP2512225A1 Use of vip3ab in combination with cry1ca for management of resistant insects
10/24/2012EP2512224A2 Modified cry1ca insecticidal cry proteins
10/24/2012EP2512223A1 Insecticidal protein combination comprising cry1ab and cry2aa for controlling european corn borer, and methods for insect resistance management
10/24/2012EP2512221A1 Combined use of cry1da and cry1fa proteins for insect resistance management
10/24/2012EP2512220A1 Insecticidal protein combinations for controlling fall armyworm and european corn borer, and methods for insect resistance managements
10/24/2012EP2512219A1 Combined use of vip3ab and cry1fa for management of resistant insects
10/24/2012EP2512218A1 Insect resistance management with combinations of cry1be and cry1f proteins
10/24/2012EP2450438A9 Cellulase preparation containing endoglucanases derived from two different types of microorganisms
10/24/2012CN1914330B Process for large scale production of plasmid DNA by e. coli fermentation
10/24/2012CN102753705A Method and materials for separating nucleic acid materials
10/24/2012CN102753700A Stacking of translational enhancer elements to increase polypeptide expression in plants
10/24/2012CN102753696A Use of cry1da in combination with cry1be for management of resistant insects
1 ... 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 ... 4023